Delivery Order SPE2DB22D2206-SPE2DB24FKM90
Award Date
9/27/24
Potential Completion Date
9/30/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,906.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The award is for the delivery of 4,565,477,796 units of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with an ultimate completion date of August 19, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $4,647.12 firm-fixed-price delivery order is for the supply of 4,566,077,237 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The award has an ultimate completion date of October 11, 2024 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The $4,647.12 Firm Fixed Price delivery order does not have a set-aside designation and has an ultimate completion date of August 19, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
This federal contract award, valued at $17,188.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order contract for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024 and is a firm fixed-price arrangement. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has...
This federal contract award, valued at $4,647.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $4,647.12, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of September 5, 2024. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical...
This federal contract award, valued at $7,229.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a completion date of March 10, 2025. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, worth $8,699.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a period of performance through November 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,647.12 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through May 31, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $4,647.12, is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, is providing these items to support DLA's mission of delivering logistics, acquisition, and technical services to the U.S. Armed...